1. Home
  2. SER vs NEUE Comparison

SER vs NEUE Comparison

Compare SER & NEUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • NEUE
  • Stock Information
  • Founded
  • SER 2017
  • NEUE 2015
  • Country
  • SER United States
  • NEUE United States
  • Employees
  • SER N/A
  • NEUE N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • NEUE
  • Sector
  • SER Health Care
  • NEUE
  • Exchange
  • SER Nasdaq
  • NEUE NYSE
  • Market Cap
  • SER 56.5M
  • NEUE 61.3M
  • IPO Year
  • SER 2018
  • NEUE 2021
  • Fundamental
  • Price
  • SER $5.40
  • NEUE $6.77
  • Analyst Decision
  • SER Strong Buy
  • NEUE Hold
  • Analyst Count
  • SER 2
  • NEUE 1
  • Target Price
  • SER $13.00
  • NEUE $7.00
  • AVG Volume (30 Days)
  • SER 23.9K
  • NEUE 5.1K
  • Earning Date
  • SER 08-08-2025
  • NEUE 08-07-2025
  • Dividend Yield
  • SER N/A
  • NEUE N/A
  • EPS Growth
  • SER N/A
  • NEUE N/A
  • EPS
  • SER N/A
  • NEUE N/A
  • Revenue
  • SER $51,000.00
  • NEUE $907,349,000.00
  • Revenue This Year
  • SER N/A
  • NEUE $33.99
  • Revenue Next Year
  • SER N/A
  • NEUE $5.90
  • P/E Ratio
  • SER N/A
  • NEUE N/A
  • Revenue Growth
  • SER N/A
  • NEUE N/A
  • 52 Week Low
  • SER $3.81
  • NEUE $3.79
  • 52 Week High
  • SER $11.57
  • NEUE $7.66
  • Technical
  • Relative Strength Index (RSI)
  • SER 45.42
  • NEUE 44.13
  • Support Level
  • SER $5.11
  • NEUE $6.73
  • Resistance Level
  • SER $5.67
  • NEUE $6.88
  • Average True Range (ATR)
  • SER 0.38
  • NEUE 0.09
  • MACD
  • SER -0.01
  • NEUE -0.01
  • Stochastic Oscillator
  • SER 38.52
  • NEUE 18.18

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.

Share on Social Networks: